TKCI
TurnKey Capital, Inc. [TKCI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
TKCI Stock Summary
In the News
TKCI Financial details
Company Rating
Sell
Market Cap
1.06M
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-3.25
Forward P/E
-
PEG
-
P/S
-
P/B
-0.92
P/C
-
P/FCF
-15.74
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-12698%
ROE
33%
ROC
0.28%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.5-2.5
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
TKCI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.15 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.86 | -0.77 | -1.21 | 0 | 0 | |
| Operating cash flow per share | -0.13 | -0.16 | 0.61 | 0 | 0 | |
| Free cash flow per share | -0.13 | -0.16 | 0.61 | 0 | 0 | |
| Cash per share | 0.01 | 0 | 0.76 | 0 | 0 | |
| Book value per share | -2.02 | -2.71 | -2.59 | 0 | 0 | |
| Tangible book value per share | -2.02 | -2.71 | -2.59 | 0 | 0 | |
| Share holders equity per share | -2.02 | -2.71 | -2.59 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 854.27K | 845.4K | 100.93K | 0 | 0 | |
| Enterprise value | 850.87K | 844.15K | -281.25K | 0 | 0 | |
| P/E ratio | -2.44 | -2.6 | -0.17 | 0 | 0 | |
| Price to sales ratio | 14.24 | 0 | 0 | 0 | 0 | |
| POCF ratio | -16.71 | -12.59 | 0.33 | 0 | 0 | |
| PFCF ratio | -16.05 | -12.59 | 0.33 | 0 | 0 | |
| P/B Ratio | -1.04 | -0.74 | -0.08 | 0 | 0 | |
| PTB ratio | -1.04 | -0.74 | -0.08 | 0 | 0 | |
| EV to sales | 14.18 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -3.84 | -2.6 | 0.46 | 0 | 0 | |
| EV to operating cash flow | -16.64 | -12.57 | -0.91 | 0 | 0 | |
| EV to free cash flow | -15.98 | -12.57 | -0.91 | 0 | 0 | |
| Earnings yield | -0.41 | -0.38 | -6.03 | 0 | 0 | |
| Free cash flow yield | -0.06 | -0.08 | 3.05 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0.02 | 0 | 0.63 | 0 | 0 | |
| Current ratio | 0 | 0 | 0.23 | 0 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0.15 | 0.21 | -0.51 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 4.33 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.04 | 0 | 0 | 0 | 0 | |
| Capex to revenue | -0.04 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -7.02 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 6.25 | 6.84 | 8.41 | 0 | 0 | |
| ROIC | 0.17 | 0.28 | 0.47 | 0 | 0 | |
| Return on tangible assets | -67.41 | -126.98 | -1.58 | 0 | 0 | |
| Graham Net | -2.02 | -2.71 | -2.6 | 0 | 0 | |
| Working capital | -821.76K | -1.15M | -1.3M | 0 | 0 | |
| Tangible asset value | -819.96K | -1.14M | -1.3M | 0 | 0 | |
| Net current asset value | -821.76K | -1.15M | -1.3M | 0 | 0 | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 194.66K | 441.63K | 285.11K | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 416.26K | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.43 | 0.28 | 0.47 | 0 | 0 | |
| Capex per share | -0.01 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | |
| P/E ratio | 0 | 0 | 0 | 0 | 0 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
| PTB ratio | 0 | 0 | 0 | 0 | 0 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
| Current ratio | 0 | 0 | 0 | 0 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | 0 | 0 | 0 | 0 | 0 | |
| Working capital | 0 | 0 | 0 | 0 | 0 | |
| Tangible asset value | 0 | 0 | 0 | 0 | 0 | |
| Net current asset value | 0 | 0 | 0 | 0 | 0 | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | 0 | 0 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
TKCI Frequently Asked Questions
What is TurnKey Capital, Inc. stock symbol ?
TurnKey Capital, Inc. is a US stock , located in Ft. lauderdale of Fl and trading under the symbol TKCI
What is TurnKey Capital, Inc. stock quote today ?
TurnKey Capital, Inc. stock price is $- today.
Is TurnKey Capital, Inc. stock public?
Yes, TurnKey Capital, Inc. is a publicly traded company.
Company Profile
- Market Capitalization 1.06M
- CEO Mr. Neil B. Swartz CPA
- Headquarters Ft. Lauderdale,FL,US
- IPO Date 2014-01-07
-
Website
https://healthspanmed.org 
HealthSpan Medical Systems, Inc. develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners. The company was incorporated in 2018 and is headquartered in Ft. Lauderdale, Florida.
